| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 03/10/2010 | EP1114061B1 FACTOR VIIa INHIBITORS |
| 03/10/2010 | CN101668769A Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors |
| 03/09/2010 | US7674775 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 03/09/2010 | US7674771 laminin binding site |
| 03/09/2010 | US7674768 Processes for preparing eptifibatide |
| 03/09/2010 | US7674752 Functional protein arrays |
| 03/09/2010 | US7674451 Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes |
| 03/09/2010 | CA2306313C Dipeptide nitriles |
| 03/09/2010 | CA2140598C Prolineamide derivatives |
| 03/04/2010 | WO2010023364A1 Process for improving taste of product |
| 03/04/2010 | WO2010006605A3 Thrombin substrate and assay for determining the level of bioactive thrombin in a sample |
| 03/04/2010 | WO2009110952A3 Control of viral-host membrane fusion with hydrogen bond surrogate-based artificial helices |
| 03/04/2010 | WO2009003284A8 Novel peptides, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same |
| 03/04/2010 | US20100056756 Compounds and compositions as channel activating protease inhibitors |
| 03/04/2010 | US20100056755 Process for Making Bivalirudin |
| 03/04/2010 | US20100056551 Anti-cancer cyclopenta [G] quinazoline compounds |
| 03/04/2010 | US20100056458 Peptides Inhibiting Angiotensin-Converting Enzyme |
| 03/04/2010 | US20100056457 Zinc Finger Binding Domains for CNN |
| 03/04/2010 | US20100056435 Depsipeptides and Their Therapeutic Use |
| 03/04/2010 | US20100056432 Template-fixed peptidomimetics with antibacterial activity |
| 03/04/2010 | US20100055737 Cyclodipeptide Synthetase and its use for Synthesis of Cyclo(Tyr-Xaa) Cyclodipeptides |
| 03/03/2010 | EP2159229A1 High purity lipopeptides, lipopeptide micelles and processes for preparing same |
| 03/03/2010 | EP1730166B1 Process for preparing macrocyclic dipeptides which are suitable for the treatment of hepatitis c viral infections |
| 03/03/2010 | CN101663314A crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
| 03/03/2010 | CN101659691A Industrial process for producing glutamine dipeptide |
| 03/02/2010 | US7671215 Process for the preparation of compounds having an ace inhibitory action |
| 03/02/2010 | US7671176 host cells that contain an isolated nucleic acid molecule that encodes a polypeptide having mu3 opiate receptor activity; for identifying mu3 opiate receptor agonists and antagonists |
| 03/02/2010 | US7671175 animal feed additive; detergent; defensins; exhibit reduced hemolytic activity, cytotoxicity and sensitivity towards cations, such as Ca2+, Mg2+, Na+. |
| 03/02/2010 | US7671082 4-Amino-2,2-dioxo-2 lambda 6-thia-bicyclo[3.1.0]hexane-4,6-dicarboxylic acid diethyl ester; glutamate receptor agonist; antidepressant, anxiolytic agent psychological, and psychiatric disorders; acylation amino compounds with amino acyl, deprotection |
| 03/02/2010 | US7671032 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV) |
| 03/02/2010 | US7671028 Peptides that antagonize FPR class receptor mediated signaling |
| 03/02/2010 | US7671009 Wound healing agents; hydration; wrinkle resistance; aging resistance; radiation resistance; forming collagen, , fibronectin |
| 02/25/2010 | WO2009118375A3 Stabilized liquid enzyme compositions |
| 02/25/2010 | WO2008132731A3 Methods and compositions for rectal administration of insulin |
| 02/25/2010 | US20100048865 Microwave-assisted peptide synthesis |
| 02/25/2010 | US20100047841 Synthesis of desacetoxytubulysin h and analogs thereof |
| 02/25/2010 | US20100047240 Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors |
| 02/24/2010 | EP2157188A1 Method for producing alpha-L-Aspartyl-L-phenylalanine-Beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester |
| 02/24/2010 | EP2157097A1 Specific binding agents of human angiopoietin-2 |
| 02/24/2010 | EP2156846A1 Prophylactic or therapeutic agent for diarrhea |
| 02/24/2010 | EP2155892A2 Novel peptidase substrates |
| 02/24/2010 | EP2155776A2 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof |
| 02/24/2010 | EP2155775A2 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof |
| 02/24/2010 | EP1971580B1 Piperazine compounds with a herbicidal action |
| 02/24/2010 | EP1572066B1 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 02/24/2010 | EP1509300B2 Production of crystalline materials by using high intensity ultrasound |
| 02/24/2010 | EP1471936B1 Hiv vaccine and method of use |
| 02/24/2010 | EP1290011B1 Melphalan derivatives and their use as cancer chemotherapeutic drugs |
| 02/24/2010 | CN101654473A Synthesis method of amino-protecting glycine dipeptidase derivant |
| 02/24/2010 | CN100591690C Solid phase peptide sythesis |
| 02/24/2010 | CN100591689C Solid salts of benzazepine compounds and its uses in preparing pharmaceutical compound containing them |
| 02/23/2010 | US7666987 For detection of caspases, trypsin and tryptase; comprises luciferase and amino-modified aminoluciferin or a carboxy-terminal protected derivative; solid phase synthesis |
| 02/23/2010 | US7666986 Biologically active peptide comprising tyrosyl-seryl-valine (YSV) |
| 02/23/2010 | US7666984 Consisting of the amino acid sequence ALFDGDPHL, the peptide having the ability to bind to a molecule of human major histocompatibility complex class-I; use in immunotherapy of tumor-associated diseases and/or adenomatous diseases |
| 02/23/2010 | US7666983 peptides that activate the DNA binding activity of the wild-type form of the p53 tumor suppressor, as well as of certain tumor-derived p53 mutants |
| 02/23/2010 | US7666896 improved method; chemical condensation in presence of catalytic hydrogenation catalyst; hydrogenolysis; amidation; angiotensin-converting enzyme (ACE) inhibitor; hypotensive agent for treating hypertension and congestive heart failure |
| 02/23/2010 | US7666842 Elastin peptide analogs and uses thereof |
| 02/23/2010 | US7666429 Nucleic acids encoding a house dust mite allergen Der P III, and uses therefor |
| 02/23/2010 | US7666428 Recombinant allergen with reduced IgE binding but undiminished T-cell antigenicity |
| 02/23/2010 | US7666422 Methods for the treatment of cancer using anti-CD40 antibodies |
| 02/23/2010 | US7666415 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 02/23/2010 | US7666408 Virus-like particle of an RNA bacteriophage carrier attached to an angiotensin peptide through a nonpeptide bond to form an ordered and repetitive angiotensin peptide-carrier conjugate; treating/preventing hypertension, stroke, infarction, congestive heart failure, kidney failure and retinal hemorrhage |
| 02/23/2010 | US7666391 Therapeutic treating breast cancer |
| 02/18/2010 | US20100041639 Cyclic malonamides as inhibitors of a beta protein production |
| 02/18/2010 | US20100041615 Protein-binding methotrexate derivatives, and medicaments containing the same |
| 02/18/2010 | US20100041591 Hcv protease inhibitors and uses thereof |
| 02/18/2010 | US20100041568 Tripodal cyclohexane derivatives and their use as carbohydrate receptors |
| 02/18/2010 | US20100041162 Use of arylboronic acids in protein labelling |
| 02/18/2010 | US20100040664 Aabb-poly(depsipeptide) biodegradable polymers and methods of use |
| 02/18/2010 | US20100040542 Chelator conjugates |
| 02/17/2010 | EP2152725A1 Crystalline and amorphous forms of peptide |
| 02/17/2010 | EP1633774B1 Macrocyclic antagonists of the motilin receptor |
| 02/17/2010 | CN101652383A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 02/17/2010 | CN101652382A Formation of organic nanostructure array |
| 02/17/2010 | CN101652381A Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them |
| 02/16/2010 | US7662913 Inclusion body tags for use as molecular beacon in identification of heterologous polypeptides |
| 02/16/2010 | US7662857 Diagnostic agents for pancreatic exocrine function |
| 02/16/2010 | US7662789 Peptide substance restoring myocardium function |
| 02/16/2010 | US7662781 Immunopotentiating agent |
| 02/16/2010 | US7662779 Triazolyl macrocyclic hepatitis C serine protease inhibitors |
| 02/16/2010 | US7662778 a compound containing cyclic tetrapeptide coupled to amide, ester, ketone groups; apoptosis and cell differentiation inducer; cancer metastasis and angiogenesis inhibitor; catalytic hydrogenation, acid treatment, fluoride anion treatment, or hydrolysis for deblocking; coupling cyclic tertrapeptide |
| 02/11/2010 | WO2010015090A1 Functionalized pyrrolidines and use thereof as iap inhibitors |
| 02/11/2010 | US20100035826 Controlled release of phenolic opioids |
| 02/11/2010 | US20100035361 Two helix binders |
| 02/11/2010 | US20100034886 Polyglutamic Acids Functionalised by Histidine Derivatives and Hydrophobic Groups and the Uses Thereof, in Particular for Therapeutic Purposes |
| 02/10/2010 | EP2151451A1 Composition for preventing or treating lung disease |
| 02/10/2010 | EP2150558A1 Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors |
| 02/10/2010 | EP2150267A1 Pharmaceutical and/or cosmetic composition containing a cytochrome c-activating active ingredient |
| 02/09/2010 | US7660677 Method of designing physiologically active peptide and use thereof |
| 02/09/2010 | US7659383 Canine and feline 5T4 polypeptide sequences for use in generating vaccine for prevention and treatment of cell proliferative disorders; veterinary medicine |
| 02/09/2010 | US7659255 Methods of inhibiting glutamate receptors by administering the tripeptide KDI |
| 02/09/2010 | US7659244 Rapamycin peptides conjugates: synthesis and uses thereof |
| 02/09/2010 | CA2392033C Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
| 02/09/2010 | CA2363934C Oligomers substituted by phosphite ester, phosphonic acid,or carbaborane functions and the corresponding pna monomers |
| 02/04/2010 | WO2010013555A1 Novel lipid dipeptide and gel |
| 02/04/2010 | WO2009003283A8 Novel compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same |
| 02/04/2010 | US20100029575 N-Oxides of Kappa Receptor Peptides |
| 02/04/2010 | US20100029552 Peptide inhibitors of c-jun dimerization and uses thereof |
| 02/04/2010 | US20100028300 Macrocyclic peptides active against the hepatitis c virus |
| 02/03/2010 | EP2149582A1 Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereof |